Literature DB >> 12876477

Cellular prion protein ablation impairs behavior as a function of age.

Adriana S Coitinho1, Rafael Roesler, Vilma R Martins, Ricardo R Brentani, Ivan Izquierdo.   

Abstract

Cellular prion protein (PrPc) has been associated with some physiological functions in recent reports. Here we investigate behavioral parameters in 3- and 9-month-old mice lacking PrPc protein (Prnp0/0) and in rats after intrahippocampal administration of affinity purified anti-PrPc IgG (0.09 microg/side). No differences were observed between 3-month-old animals. However, 9-month-old Prnp0/0 mice and rats infused with anti-PrPc antibody showed a clear impairment of short- and long-term memory retention of a step-down inhibitory avoidance task. A decreased locomotor activity during exploration of an open field was also observed. These results suggest that systems involved in memory formation become more susceptible to mechanisms that require PrPc between the ages of 3 and 9 months in both mice and rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876477     DOI: 10.1097/01.wnr.0000078541.07662.90

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

Review 1.  Prion potency in stem cells biology.

Authors:  Marilene H Lopes; Tiago G Santos
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 2.  The molecular cascades of long-term potentiation underlie memory consolidation of one-trial avoidance in the CA1 region of the dorsal hippocampus, but not in the basolateral amygdala or the neocortex.

Authors:  Iván Izquierdo; Lia R M Bevilaqua; Janine I Rossato; Weber C da Silva; Juliana Bonini; Jorge H Medina; Martín Cammarota
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

3.  Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.

Authors:  Laura McCulloch; Karen L Brown; Neil A Mabbott
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

4.  A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.

Authors:  Danielle Beckman; Rafael Linden
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

5.  Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression.

Authors:  Matthias Schmitz; Catharina Greis; Philipp Ottis; Christopher J Silva; Walter J Schulz-Schaeffer; Arne Wrede; Katharina Koppe; Bruce Onisko; Jesús R Requena; Nambirajan Govindarajan; Carsten Korth; Andre Fischer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2014-03-07       Impact factor: 5.590

6.  Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrP(C)-deficiency.

Authors:  Nathalie Daude; Serene Wohlgemuth; Rebecca Brown; Rose Pitstick; Hristina Gapeshina; Jing Yang; George A Carlson; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

Review 7.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Authors:  Wen-Quan Zou; Xiaochen Zhou; Jue Yuan; Xiangzhu Xiao
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

8.  Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

9.  Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression.

Authors:  Karah E Nazor; Tanya Seward; Glenn C Telling
Journal:  Biochim Biophys Acta       Date:  2007-04-24

10.  Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice.

Authors:  Alejandra Rangel; Noelia Madroñal; Agnès Gruart; Agnès Gruart i Massó; Rosalina Gavín; Franc Llorens; Lauro Sumoy; Juan María Torres; José María Delgado-García; José Antonio Del Río
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.